Genetically Engineered Vaccines - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Genetically Engineered Vaccines Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Genetically Engineered Vaccines Market Restraints
Table 3. Genetically Engineered Vaccines Market Trends
Table 4. Genetically Engineered Vaccines Industry Policy
Table 5. Global Genetically Engineered Vaccines Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Genetically Engineered Vaccines Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Genetically Engineered Vaccines Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Genetically Engineered Vaccines Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Genetically Engineered Vaccines Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Genetically Engineered Vaccines Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Genetically Engineered Vaccines Mergers & Acquisitions, Expansion Plans
Table 12. Global Genetically Engineered Vaccines Manufacturers Product Type
Table 13. Head Office and Genetically Engineered Vaccines Production Site of Key Manufacturer
Table 14. Genetically Engineered Vaccines Capacity of Major Manufacturers and Future Plan
Table 15. China Genetically Engineered Vaccines Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Genetically Engineered Vaccines Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Genetically Engineered Vaccines Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Genetically Engineered Vaccines Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Genetically Engineered Vaccines Production by Region, 2018-2023, (K Units)
Table 20. Global Genetically Engineered Vaccines Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Genetically Engineered Vaccines Upstream (Raw Materials)
Table 22. Global Genetically Engineered Vaccines Typical Customers
Table 23. Genetically Engineered Vaccines Typical Distributors
Table 24. By Type, Global Genetically Engineered Vaccines Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Genetically Engineered Vaccines Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Genetically Engineered Vaccines Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Genetically Engineered Vaccines Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Genetically Engineered Vaccines Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Genetically Engineered Vaccines Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Genetically Engineered Vaccines Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Genetically Engineered Vaccines Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Genetically Engineered Vaccines Models, Specifications, and Application
Table 36. Pfizer Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. Merck Company Information, Head Office, Market Area, and Industry Position
Table 40. Merck Genetically Engineered Vaccines Models, Specifications, and Application
Table 41. Merck Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. GSK Company Information, Head Office, Market Area, and Industry Position
Table 45. GSK Genetically Engineered Vaccines Models, Specifications, and Application
Table 46. GSK Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. GSK Company Profile and Main Business
Table 48. GSK Recent Developments
Table 49. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information, Head Office, Market Area, and Industry Position
Table 50. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Models, Specifications, and Application
Table 51. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Profile and Main Business
Table 53. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments
Table 54. Walvax Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 55. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Models, Specifications, and Application
Table 56. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Walvax Biotechnology Co., Ltd. Company Profile and Main Business
Table 58. Walvax Biotechnology Co., Ltd. Recent Developments
Table 59. Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
Table 60. Bharat Biotech Genetically Engineered Vaccines Models, Specifications, and Application
Table 61. Bharat Biotech Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bharat Biotech Company Profile and Main Business
Table 63. Bharat Biotech Recent Developments
Table 64. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 65. Sanofi Genetically Engineered Vaccines Models, Specifications, and Application
Table 66. Sanofi Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Sanofi Company Profile and Main Business
Table 68. Sanofi Recent Developments
Table 69. Zoties Company Information, Head Office, Market Area, and Industry Position
Table 70. Zoties Genetically Engineered Vaccines Models, Specifications, and Application
Table 71. Zoties Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Zoties Company Profile and Main Business
Table 73. Zoties Recent Developments
Table 74. Elanco Company Information, Head Office, Market Area, and Industry Position
Table 75. Elanco Genetically Engineered Vaccines Models, Specifications, and Application
Table 76. Elanco Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Elanco Company Profile and Main Business
Table 78. Elanco Recent Developments
Table 79. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 80. Boehringer Ingelheim Genetically Engineered Vaccines Models, Specifications, and Application
Table 81. Boehringer Ingelheim Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Boehringer Ingelheim Company Profile and Main Business
Table 83. Boehringer Ingelheim Recent Developments
Table 84. Indian Immunologicals Company Information, Head Office, Market Area, and Industry Position
Table 85. Indian Immunologicals Genetically Engineered Vaccines Models, Specifications, and Application
Table 86. Indian Immunologicals Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Indian Immunologicals Company Profile and Main Business
Table 88. Indian Immunologicals Recent Developments
Table 89. China Animal Husbandry Industry Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 90. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Models, Specifications, and Application
Table 91. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. China Animal Husbandry Industry Co.,Ltd. Company Profile and Main Business
Table 93. China Animal Husbandry Industry Co.,Ltd. Recent Developments
Table 94. Yebio Bioengineering Co., Ltd Of Qingdao Company Information, Head Office, Market Area, and Industry Position
Table 95. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Models, Specifications, and Application
Table 96. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Yebio Bioengineering Co., Ltd Of Qingdao Company Profile and Main Business
Table 98. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments
Table 99. Jinyu Bio-technology Co.,ltd. Company Information, Head Office, Market Area, and Industry Position
Table 100. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Models, Specifications, and Application
Table 101. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Jinyu Bio-technology Co.,ltd. Company Profile and Main Business
Table 103. Jinyu Bio-technology Co.,ltd. Recent Developments
Table 104. HVRI Company Information, Head Office, Market Area, and Industry Position
Table 105. HVRI Genetically Engineered Vaccines Models, Specifications, and Application
Table 106. HVRI Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. HVRI Company Profile and Main Business
Table 108. HVRI Recent Developments
Table 109. Ringpu Biology Company Information, Head Office, Market Area, and Industry Position
Table 110. Ringpu Biology Genetically Engineered Vaccines Models, Specifications, and Application
Table 111. Ringpu Biology Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Ringpu Biology Company Profile and Main Business
Table 113. Ringpu Biology Recent Developments
Table 114. Kyoto Biken Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 115. Kyoto Biken Laboratories Genetically Engineered Vaccines Models, Specifications, and Application
Table 116. Kyoto Biken Laboratories Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Kyoto Biken Laboratories Company Profile and Main Business
Table 118. Kyoto Biken Laboratories Recent Developments
Table 119. FATRO Company Information, Head Office, Market Area, and Industry Position
Table 120. FATRO Genetically Engineered Vaccines Models, Specifications, and Application
Table 121. FATRO Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. FATRO Company Profile and Main Business
Table 123. FATRO Recent Developments
Table 124. Ceva Santé Animale Company Information, Head Office, Market Area, and Industry Position
Table 125. Ceva Santé Animale Genetically Engineered Vaccines Models, Specifications, and Application
Table 126. Ceva Santé Animale Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Ceva Santé Animale Company Profile and Main Business
Table 128. Ceva Santé Animale Recent Developments
Table 129. Pulike Biological Engineering,Inc. Company Information, Head Office, Market Area, and Industry Position
Table 130. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Models, Specifications, and Application
Table 131. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Pulike Biological Engineering,Inc. Company Profile and Main Business
Table 133. Pulike Biological Engineering,Inc. Recent Developments
Table 134. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Company Information, Head Office, Market Area, and Industry Position
Table 135. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Models, Specifications, and Application
Table 136. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 137. Wuhan Hvsen Biotechnology CO.,LTD Company Profile and Main Business
Table 138. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments
Table 139. Jinhe Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 140. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Models, Specifications, and Application
Table 141. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 142. Jinhe Biotechnology Co., Ltd. Company Profile and Main Business
Table 143. Jinhe Biotechnology Co., Ltd. Recent Developments
Table 144. Shanghai Shen Lian Biomedical Corporation Company Information, Head Office, Market Area, and Industry Position
Table 145. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Models, Specifications, and Application
Table 146. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 147. Shanghai Shen Lian Biomedical Corporation Company Profile and Main Business
Table 148. Shanghai Shen Lian Biomedical Corporation Recent Developments
Table 149. Qingdao Vland Biotech INC. Company Information, Head Office, Market Area, and Industry Position
Table 150. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Models, Specifications, and Application
Table 151. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 152. Qingdao Vland Biotech INC. Company Profile and Main Business
Table 153. Qingdao Vland Biotech INC. Recent Developments
List of Figures
Figure 1. Genetically Engineered Vaccines Picture
Figure 2. Global Genetically Engineered Vaccines Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Genetically Engineered Vaccines Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Genetically Engineered Vaccines Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Genetically Engineered Vaccines Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Genetically Engineered Vaccines Sales Quantity (K Units) & (2018-2029)
Figure 7. China Genetically Engineered Vaccines Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Genetically Engineered Vaccines Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Genetically Engineered Vaccines Market Share of Global, 2018-2029
Figure 10. Global Genetically Engineered Vaccines Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Genetically Engineered Vaccines Key Participants, Market Share, 2022
Figure 12. Global Genetically Engineered Vaccines Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Genetically Engineered Vaccines Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Genetically Engineered Vaccines Production Market Share & Forecast by Region, 2018-2029
Figure 15. Genetically Engineered Vaccines Industry Chain
Figure 16. Genetically Engineered Vaccines Procurement Model
Figure 17. Genetically Engineered Vaccines Sales Model
Figure 18. Genetically Engineered Vaccines Sales Channels, Direct Sales, and Distribution
Figure 19. Genetic Recombinant Vaccine
Figure 20. Recombinant Subunit Vaccines
Figure 21. Genetic Vaccine
Figure 22. By Type, Global Genetically Engineered Vaccines Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Genetically Engineered Vaccines Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Genetically Engineered Vaccines Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Genetically Engineered Vaccines Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Veterinary Use
Figure 28. Human Use
Figure 29. By Application, Global Genetically Engineered Vaccines Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Genetically Engineered Vaccines Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Genetically Engineered Vaccines Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Genetically Engineered Vaccines Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Genetically Engineered Vaccines Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Genetically Engineered Vaccines Sales Quantity Market Share, 2018-2029
Figure 36. North America Genetically Engineered Vaccines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Genetically Engineered Vaccines Consumption Value Market Share, 2022
Figure 38. Europe Genetically Engineered Vaccines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Genetically Engineered Vaccines Consumption Value Market Share, 2022
Figure 40. Asia Pacific Genetically Engineered Vaccines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Genetically Engineered Vaccines Consumption Value Market Share, 2022
Figure 42. South America Genetically Engineered Vaccines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Genetically Engineered Vaccines Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Genetically Engineered Vaccines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Genetically Engineered Vaccines Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Genetically Engineered Vaccines Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets